Eye device
AssigneeEyed Pharma
InventorsJean-Marie Rakic, Jean-Michel Foidart
Life of this patent
Estimating the term…
Abstract
The invention provides a sustained release intraocular drug delivery device comprising: (a) a polymeric matrix core into which at least one therapeutic agent is mixed, and; (b) a polymeric coating completely surrounding said polymeric matrix material; wherein said polymeric matrix core and polymeric coating are insoluble and inert in ocular fluids, and wherein said sustained release intraocular drug delivery device has a compliant annular segment shape and is to be inserted into the sulcus of the intact and/or pseudophakic eye.
Claims23
A sustained release intraocular drug delivery device configured for the sulcus of the eye, comprising:
- (a) a polymeric matrix core into which at least one therapeutic agent is mixed, and;
- (b) a polymeric coating completely surrounding said polymeric matrix material;
- wherein said polymeric matrix core and polymeric coating are insoluble and inert in ocular fluids, and wherein said sustained release intraocular drug delivery device is formed of a compliant annular segment, preferably having a cross sectional diameter ranging from 0.10 to 0.80 mm.
Dependencies are inferred from the claim text.